BMRN

BioMarin Pharmaceutical (BMRN)

About BioMarin Pharmaceutical (BMRN)

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Details

Daily high
$69.00
Daily low
$68.04
Price at open
$69.00
52 Week High
$99.56
52 Week Low
$67.75
Market cap
13.1B
Dividend yield
0.00%
Volume
1.7M
Avg. volume
2.3M
P/E ratio
51.86

BioMarin Pharmaceutical News

Details

Daily high
$69.00
Daily low
$68.04
Price at open
$69.00
52 Week High
$99.56
52 Week Low
$67.75
Market cap
13.1B
Dividend yield
0.00%
Volume
1.7M
Avg. volume
2.3M
P/E ratio
51.86